SCHEMBL3446366

SCHEMBL3446366

CC(=O)Oc1ccccc1CNc1nc(NCC(C)O)nc2c1nnn2C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.46
CDK1 P06493 5/20 0.46
CCNE1 P24864 7/20 0.42
CDK5 Q00535 4/20 0.42
CDK9 P50750 3/20 0.42
CDK5R1 Q15078 3/20 0.42
CCNT1 O60563 2/20 0.42
POLB P06746 1/20 0.38
CCNB2 O95067 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
CDK7 P50613 1/20 0.37
CCNH P51946 1/20 0.37
CCNE2 O96020 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CCNA2 P20248 1/20 0.36
CCNA1 P78396 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3445015 0.92 CDK2 (0.43) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3445433 0.90 POLB (0.47) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3445451 0.89 CDK2 (0.43) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3446341 0.85 CDK1 (0.52) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3446344 0.85 CDK1 (0.52) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3444622 0.84 CDK2 (0.53) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3445310 0.84 CDK2 (0.49) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3445423 0.83 CDK2 (0.60) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3444540 0.83 CDK2 (0.52) CDK2CDK1CCNE1CDK5CDK9
SCHEMBL3446834 0.82 CDK2 (0.54) CDK2CDK1CCNE1CDK5CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816350-B2 Substituted [1,2,3] triazolo[4,5-D]pyrimidines as cdk inhibitors INSTITUTE OF EXPERIMENTAL BOTANY ASCR (CZ) 2010-10-19 US claimed